To further explore additional mechanisms of specifically enhancing PI cytotoxicity in Onc-p53 NSCLC cells, we considered whether targeting BCL-2 family antiapoptotic proteins might cooperatively improve BTZ cytotoxicity as well. The gene discussed is CASC3; the disease is non-small cell lung carcinoma.